- Home
- LNTH vs FRHC Comparison
LNTH vs FRHC Comparison
Compare LNTH & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNTH | FRHC |
|---|---|---|
| Founded | 1956 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 8.7B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | FRHC |
|---|---|---|
| Price | $66.99 | $124.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $78.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 81.6K |
| Earning Date | 11-06-2025 | 02-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.39 | 0.08 |
| Revenue | $1,525,933,000.00 | ★ $1,563,510,000.00 |
| Revenue This Year | $0.01 | N/A |
| Revenue Next Year | $0.52 | N/A |
| P/E Ratio | ★ $28.11 | $1,613.48 |
| Revenue Growth | 1.95 | ★ 16.04 |
| 52 Week Low | $47.25 | $111.85 |
| 52 Week High | $111.29 | $194.01 |
Technical Indicators
Market Signals| Indicator | LNTH | FRHC |
|---|---|---|
| Relative Strength Index (RSI) | 64.91 | 35.30 |
| Support Level | $66.36 | $120.22 |
| Resistance Level | $67.45 | $137.10 |
| Average True Range (ATR) | 1.65 | 4.73 |
| MACD | -0.15 | -0.64 |
| Stochastic Oscillator | 64.97 | 23.69 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.